Investigation of ABH Antigenicity of Random Mucosal Biopsies and Transitional Cell Carcinoma of the Urinary Bladder
- 1 January 1983
- journal article
- research article
- Published by Elsevier in European Urology
- Vol. 9 (2) , 97-101
- https://doi.org/10.1159/000474057
Abstract
Blood group isoantigens can be demonstrated immunohistologically on normal bladder urothelium by means of the specific red cell adherence test. In preneoplastic and reactive changes of the urothelium as well as in carcinoma in situ, a loss of these antigens occurs. Blood group isoantigen content decreases with higher anaplasia of transitional cell carcinoma. Overt tumors without blood group isoantigens are associated with carcinoma in situ and severe dysplasia at a high percentage. These tumors are associated significantly more often with antigen-negative light-microscopically normal-appearing urothelium than antigen-positive ones do.Keywords
This publication has 15 references indexed in Scilit:
- The Prognostic Value of Cell Surface Antigens in Low Grade, Non-Invasive, Transitional Cell Carcinoma of the BladderJournal of Urology, 1979
- Blood group isoantigen deletion in carcinomain situ of the urinary bladderCancer, 1979
- Biopsy of Apparently Normal Urothelium in Patients with Bladder CarcinomaJournal of Urology, 1978
- Serial Multiple-Site Biopsies in Patients with Bladder CancerJournal of Urology, 1978
- Isoantigens A, B and H in urinary bladder carcinomas following radiotherapyCancer, 1978
- Tissue Blood-Group Antigens and Prognosis in Low Stage Transitional Cell Carcinoma of the BladderJournal of Urology, 1978
- The Cell Surface Antigen A, B or O(h) as an Indicator of Malignant Potential in Stage a Bladder Carcinoma: Preliminary ReportJournal of Urology, 1978
- Random Mucosal Biopsies in the Evaluation of Patients with Carcinoma of the BladderJournal of Urology, 1977
- Carcinogenesis in the Human Urinary BladderNew England Journal of Medicine, 1965
- A and B Antigens of Tumors Arising From Urinary EpitheliumJNCI Journal of the National Cancer Institute, 1961